Network origin in Thomas Wirth first degree
Entity | Entity type | Industry | |
---|---|---|---|
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland.
9
| Holding Company | Biotechnology | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Wirth via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
SYNAIRGEN PLC | Pharmaceuticals: Major | Director/Board Member | |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
University of St. Gallen | College/University | Masters Business Admin | |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of St. Andrews | College/University | Undergraduate Degree | |
Charles River Discovery Research Services Finland Oy
Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharmatest Services Oy
Pharmatest Services Oy Miscellaneous Commercial ServicesCommercial Services Pharmatest Services Oy offers translational research services for diseases with unmet clinical needs. It provides full-service research solutions for early drug development. Its focus is on preclinical efficacy models in the fields of cancer and skeletal diseases ranging from in vitro cell culture assays to in vivo models. In addition, the firm develops model and assay development services for its customers. The company was founded by Jussi Halleen and Pirkko Härkönen in 1998 and is headquartered in Turku, Finland. | Miscellaneous Commercial Services | Director/Board Member | |
University of Zurich | College/University | Doctorate Degree | |
SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
Cilag AG
Cilag AG Miscellaneous Commercial ServicesCommercial Services Cilag AG conducts pharmaceutical research and development activities. It is an international operating company integrated in the pharmaceuticals group of Johnson & Johnson that provides its customers with APIs, health care and pharmaceutical products worldwide. The company was founded in 1936 by Dr. Bernhard Joos and is headquartered in Schaffhausen, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Vertex Pharmaceuticals (Europe) Ltd.
Vertex Pharmaceuticals (Europe) Ltd. Medical DistributorsDistribution Services Vertex Pharmaceuticals (Europe) Ltd. operates as a pharmaceutical firm. The company was founded on March 11, 1994 and is headquartered London, the United Kingdom. | Medical Distributors | Chief Executive Officer | |
Biogen SA | Sales & Marketing | ||
Osuuskunta KPY
Osuuskunta KPY Financial ConglomeratesFinance Osuuskunta KPY operates as a long-term investor. It also rents office space and invests in securities. The company was founded in 1883 and is headquartered in Kuopio, Finland. | Financial Conglomerates | Director/Board Member | |
Spirig Pharma AG
Spirig Pharma AG Pharmaceuticals: MajorHealth Technology Spirig Pharma AG manufactures and distributes pharmaceutical products. The company was founded in 1948 and is headquartered in Egerkingen, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Investment Managers | Director/Board Member | |
Helvecura Cooperative Society | Director/Board Member | ||
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Krebsforschung Schweiz | Director/Board Member | ||
Hänseler Holding AG | Chairman | ||
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Biotechnology | Director/Board Member | |
Allecra Therapeutics GmbH
Allecra Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Allecra Therapeutics GmbH focuses on the development of novel treatments to combat multi drug-resistant bacterial infections. The firm serves the bio and pharmaceutical industry. The company was founded by Nicholas Benedict and Stuart Shapiro in 2013 and is headquartered in Weil am Rhein, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Swiss Cancer Foundation | Director/Board Member | ||
University of Eastern Finland | College/University | Doctorate Degree | |
PIQUR Therapeutics AG
PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Nostetta Oy
Nostetta Oy Investment ManagersFinance Nostetta Oy (Nostetta) is a venture capital firm founded in 2013. The firm is headquartered in Kuopio, Finland. | Investment Managers | Director/Board Member | |
Clarena AG
Clarena AG Miscellaneous Commercial ServicesCommercial Services Clarena AG provides business management consultancy services. The private company is based in Basel, Switzerland. The Swiss company was founded by Roger Meier. | Miscellaneous Commercial Services | Founder | |
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Founder | |
Mavena International AG
Mavena International AG Pharmaceuticals: MajorHealth Technology Mavena International AG develops, manufactures, and markets medical care products for the treatment of chronic skin conditions. The company is headquartered in Huneberg, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Strekin AG
Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company is based in Basel, Switzerland and was founded in 2014. | Biotechnology | Director/Board Member Director/Board Member | |
Hthc High Tech Home Care AG | Chairman | ||
Just Finance AG | Director/Board Member | ||
Vital Solutions Swiss AG | Chairman | ||
terreActive AG
terreActive AG Information Technology ServicesTechnology Services Part of Die Schweizerische Post AG, terreActive AG is a company that specializes in soar, security orchestration automation and response, ki, ai. The company is based in Aarau, Switzerland. terreActive was acquired by Die Schweizerische Post AG on July 04, 2023. The Swiss company's Security Operations Center is responsible for protecting the IT security infrastructure and preventing cyber attacks. The company was founded in 1996 by Marc-Yves Bächli, Roger Meier. Urs Rufer has been the CEO of the company since 1999. | Information Technology Services | Founder | |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member | |
Helvecura Genossenschaft | Director/Board Member | ||
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Pharmaceuticals: Major | Director/Board Member Founder | |
Versameb AG
Versameb AG Miscellaneous Commercial ServicesCommercial Services Versameb AG operates as an preclinical-stage biopharmaceutical company. The company was founded by Friedrich Metzger, Roger Meier and Urs Breitenstein in 2018 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Founder | |
Nemis Technologies AG
Nemis Technologies AG Miscellaneous Commercial ServicesCommercial Services Nemis Technologies AG provides food safety solutions through their n-light environmental monitoring series. The company is based in Dübendorf, Switzerland and was founded in 2018 by Roger Meier, Arnaud Muller, Mario Hupfeld, and Urs Breitenstein. The Swiss company's E.coli rapid test is a part of this series and enables pathogen detection in food processing. Arnaud Muller has been the CEO since 2018. | Miscellaneous Commercial Services | Founder | |
Acthera Therapeutics AG
Acthera Therapeutics AG BiotechnologyHealth Technology Acthera Therapeutics AG is a Swiss biotechnology company that develops synthetic lipid membrane vesicles. The private company is based in Basel, Switzerland. The CEOs are Carlo Bertozzi, Pierre-Alain Monnard. The company was founded by Roger Meier. | Biotechnology | Founder | |
Celloryx AG | Director/Board Member |
Statistics
International
Switzerland | 33 |
Finland | 6 |
United Kingdom | 5 |
Germany | 3 |
United States | 2 |
Sectoral
Health Technology | 19 |
Commercial Services | 8 |
Consumer Services | 5 |
Finance | 4 |
Technology Services | 3 |
Operational
Director/Board Member | 36 |
Founder | 9 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 7 |
Chairman | 6 |
Most connected contacts
- Stock Market
- Insiders
- Thomas Wirth
- Company connections